MTOR and neoplasm: Comparing primary tumor and brain metastases samples from the same patient, we observed increased mTORC1 activity in metastases; in 60% of the cases, p-mTOR and p-S6 expression was increased in brain metastases, whereas in 40% of cases, Rictor expression was increased in brain metastases.